title: SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils.
abstract: There is a great deal of interest in determining what regulates the generation of classically activated (M1) vs alternatively activated (M2) macrophages (Mphis) because of the opposing effects that these two Mphi subsets have on tumor progression. We show herein that IL-3 and, to a lesser extent, GM-CSF skew murine Mphi progenitors toward an M2 phenotype, especially in the absence of SHIP. Specifically, the addition of these cytokines, with or without M-CSF, to adherence- or lineage-depleted (Lin(-)) SHIP(-/-) bone marrow (BM) cells induces high levels of the M2 markers, arginase I, and Ym1 in the resulting mature Mphis. These in vitro-derived mature Mphis also display other M2 characteristics, including an inability to enhance anti-CD3-stimulated splenic T cell secretion of IFN-gamma and low IL-12 and high IL-10 production in response to LPS. Not surprisingly, given that IL-3 and GM-CSF utilize STAT5 to trigger many downstream signaling pathways, this M2 phenotype is suppressed when STAT5(-/-) BM cells are used. Unexpectedly, however, this M2 phenotype is also suppressed when STAT6(-/-) BM cells are used, suggesting that IL-4- or IL-13-induced signaling might be involved. Consistent with this, we found that IL-3 and GM-CSF stimulate the production of IL-4, especially from SHIP(-/-) Lin(-) BM cells, and that neutralizing anti-IL-4 Abs block IL-3-induced M2 skewing. Moreover, we found that basophil progenitors within the Lin(-) BM are responsible for this IL-3- and GM-CSF-induced IL-4 production, and that SHIP represses M2 skewing not by preventing skewing within Mphis themselves but by inhibiting IL-4 production from basophils.
authors.affiliation: Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
authors.forename: Etsushi
authors.initials: E
authors.lastname: Kuroda
authors.forename: Victor
authors.initials: V
authors.lastname: Ho
authors.forename: Jens
authors.initials: J
authors.lastname: Ruschmann
authors.forename: Frann
authors.initials: F
authors.lastname: Antignano
authors.forename: Melisa
authors.initials: M
authors.lastname: Hamilton
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Rauh
authors.forename: Andrey
authors.initials: A
authors.lastname: Antov
authors.forename: Richard A
authors.initials: RA
authors.lastname: Flavell
authors.forename: Laura M
authors.initials: LM
authors.lastname: Sly
authors.forename: Gerald
authors.initials: G
authors.lastname: Krystal
mesh_terms: D000818:Animals; D001491:Basophils / Q000378:metabolism*; D002454:Cell Differentiation / Q000276:immunology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D000072181:Inositol Polyphosphate 5-Phosphatases; D007377:Interleukin-3 / Q000494:pharmacology*; D015847:Interleukin-4 / Q000096:biosynthesis*; D008262:Macrophage Activation; D008264:Macrophages / Q000166:cytology*; D051379:Mice; D010744:Phosphoric Monoester Hydrolases / Q000502:physiology*; D013234:Stem Cells / Q000166:cytology
chemical_list: D007377:Interleukin-3; D015847:Interleukin-4; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D010744:Phosphoric Monoester Hydrolases; D000072181:Inositol Polyphosphate 5-Phosphatases